Troponin I and cardiovascular risk prediction in the general population
Nataliya Makarova(German Centre for Cardiovascular Research), Kari Kuulasmaa(Finnish Institute for Health and Welfare), Philipp S. Wild(Johannes Gutenberg University Mainz), Brendan M. Everett(Cedars-Sinai Medical Center), Wolfgang Köenig(German Centre for Cardiovascular Research), Stefan Blankenberg(Universität Hamburg), John Yarnell, Frank Kee(Queen's University Belfast), Francisco Ojeda(Universidad Complutense de Madrid), Veikko Salomaa(Finnish Institute for Health and Welfare), Michael A. Nauck(Katholisches Klinikum Bochum), Thomas Zeller(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Torben Jørgensen(University of Copenhagen), Giovanni Veronesi(University of Insubria), Barbara Thorand(Helmholtz Zentrum München)
Site cant be reached
January 1, 2016
Cited by 0
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Richness of human gut microbiome correlates with metabolic markers
|Nature|2013|4.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Large-scale association analyses identify host factors influencing human gut microbiome composition
|Nature Genetics|2021|1.9k